Technical Articles

ActRIIA Enzyme Activity Inhibitor Screening Kit

ActRIIA-Targeted Drug Development: From Signaling Pathways to Enzyme Activity Inhibition Screening

2026-07-28

This article systematically elaborates on the structural characteristics, signal transduction mechanisms, and pathological significance of ActRIIA (activin type IIA receptor) as a key receptor in the TGF-β superfamily, analyzing its potential as a drug target in various diseases.

View details

Drug Research
ActRIIA Enzyme Activity Inhibitor Screening Kit

Total 1

Go to